AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02875106 — intervention group
Intervention type: DEVICE
Intervention: TomTom Runner Cardio HRM
Description: routine recording will be 300 seconds
Study NCT02985736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topicort Topical Spray
Study NCT03049813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Job Interview Training
Description: Job interview training using virtual reality software created by SIMmersion, Inc, in addition to standard supported employment services.
Study NCT03049813 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Supported Employment (Services as Usual)
Description: Standard supported employment services.
Study NCT02369497 — intervention group
Intervention type: DEVICE
Intervention: HRA
Description: Humeral head resurfacing with the HRA device
Study NCT03377621 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration
Description: Whole Body Vibration Machine from the company Confidence Fitness
Study NCT06572488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-ablative SMOOTH mode Er:YAG laser
Description: Four intravaginal treatments within four months.
Study NCT02061241 — intervention group
Intervention type: PROCEDURE
Intervention: Pacing in vein at site of latest mechanical activation
Description: Pacing in vein at site of latest mechanical activation
Study NCT02061241 — intervention group
Intervention type: PROCEDURE
Intervention: Pacing in other suitable vein
Description: Pacing in other suitable vein
Study NCT03086798 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magill forceps
Description: Magill forceps techniques to facilitate nasotracheal tube advancement into trachea
Study NCT03086798 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cuff inflation
Description: cuff inflation techniques to facilitate nasotracheal tube advancement into trachea
Study NCT04512274 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Article
Description: Omeza Collagen Matrix
Study NCT01866709 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium polystyrene sulfonate
Description: Oral suspension in water of 15g sodium polystyrene sulfonate administered three times (tid) daily for 48 hours without co-administration of Sorbitol.
Study NCT01866709 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Silicified microcrystalline cellulose
Description: Oral suspension in water of placebo administered three times (tid) daily for 48 hours.
Study NCT01790412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise group
Description: Combined two land aerobic sessions and one aquatic activities session
Study NCT01233297 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin
Description: 10 mg/kg peroral for 3 consecutive days
Study NCT01233297 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo mixture
Description: Placebo mixture containing no active substance.
Study NCT03221413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial alternating current stimulation (tACS)
Study NCT00627406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buserelin and Pregnyl
Description: Subcutaneous injection 0.5 mg and 1500 IU
Study NCT00627406 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregnyl
Description: Subcutaneous injection 5000 IU
Study NCT00627406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buserelin and Pregnyl
Description: Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days
Study NCT02705131 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Balance Chiropractic Therapy
Description: patients are in the sitting position and receive the following treatments.1)Balancing tendon-regulation;2) Balancing osteopathy;3) Balance collaterals-dredging.
Study NCT02705131 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traction Therapy
Description: patients will received the traction therapy.The patient is sitting and wearing a cloth bag occipital jaw traction comfortable,with head bending forward about 10-15 degrees in comfort.The weight for traction of cervical spondylosis is started at 3 kg, and gradually increased to the maximum weight not more than 6kg according to the standard of 0.5kg each time. The treatment is performed 30 minutes a time per day, 10 times as a course,a total of 2 courses.
Study NCT00626574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epoetin alfa
Description: Intravenous administration of epoetin alfa (40,000 IU) immediately before clipping surgery. Successive doses will be given 24 and 48 hours after the first dose.
Study NCT00626574 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: 3ml of saline will be administered via an IV push immediately before clipping surgery. Successive doses will be given 24 and 48 hours after the first dose.
Study NCT03387735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Treatment as usual (TAU) + Internet
Description: Patients in this group will receive TAU+internet and links to helpful websites.
Study NCT03387735 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU + ElderTree
Description: For the patient, ElderTree provides tools, motivation, and social support to help them manage their specific set of chronic conditions and communicate with peers and their primary care physician.~For the clinic, ElderTree has a Clinician Report (CR), a visual dashboard of health-tracking data that can be customized based on the needs of the clinic. The CR provides alerts to the clinician when a patient passes a certain threshold. The dashboard is intended to help clinicians prepare for patient office visits.
Study NCT02516917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Training Technique
Study NCT02723760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 99mTc-3PRGD2
Description: SPECT/CT scanning: single intravenous bolus injection of nearly 11.1 MBq/kg body weight of 99mTc-3PRGD2 on rheumatoid arthritis patients, whole-body planar and lesions section for determination the accumulation of 99mTc-3PRGD2 in the joints and other parts of the body.~For diagnosis study, each patient will be carried out SPECT/CT scanning once. For efficacy evaluation study, each patient will be carried out SPECT/CT scanning three times (before treatment, the midterm treatment and late stage treatment).
Study NCT02072850 — intervention group
Intervention type: DEVICE
Intervention: Coronary pressure wire
Description: Guidewire-based coronary pressure- and temperature recordings (coronary thermodilution) with and without hyperaemia induced by intravenous administration of adenosine (140 ug/kg/min) in patients with acute ST-elevation myocardial infarction treated by emergency PCI.
Study NCT02072850 — intervention group
Intervention type: OTHER
Intervention: Magnetic resonance imaging of the heart
Description: Cardiac magnetic resonance imaging (MRI) with gadolinium contrast imaging at baseline (\~ day 2) and 6 months (all participants) and in 30 subjects at 4 time-points (\< 12 hours, days 2, 7-10 and at 6 months).
Study NCT01122966 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: intraocular injections of bevacizumab
Description: intracameral and subconjunctival injections
Study NCT02384603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Global postural reeducation
Study NCT02384603 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Segmental muscle stretching exercises
Study NCT02384603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Study NCT02384603 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy
Study NCT04783129 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education program based on 10 monthly lectures
Description: The education program consist of 10 lectures on the management of motor and non-motor alterations associate with PD will be offered by a nurse, physiotherapist, occupational therapist, speech therapist, neurologist, lawyer, nutritionist, and psychologist.
Study NCT04783129 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education program based on 10 monthly lectures
Description: The education program consist of 10 lectures on the management of motor and non-motor alterations associate with PD will be offered by a nurse, physiotherapist, occupational therapist, speech therapist, neurologist, lawyer, nutritionist, and psychologist.
Study NCT04783129 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No intervention
Description: Participants will follow no education program (lecture) and will be instructed to follow their usual routine for the treatment of the disease
Study NCT01049659 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neuropsychological test
Description: Bayley test (version III) which provides several scales of development. Children are assessed just one time at two year old
Study NCT04668131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate eye drops
Description: eye drops, three times a day
Study NCT01974050 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Text message surveillance
Study NCT04391010 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Surgical masks
Description: Surgical masks will be applied in health care providers
Study NCT04391010 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Filtering respirators
Description: Filtering respirators will be applied in health care providers
Study NCT01935011 — intervention group
Intervention type: OTHER
Intervention: PD, DBS
Description: PD DBS frequency on swallowing function
Study NCT03968952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SMARThealth Pregnancy
Description: Education and Training package on high-risk pregnancies and the associated long-term cardiometabolic risks; An mHealth platform providing mobile decision support to Community Health Workers.
Study NCT03877393 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation + gluten-free diet
Description: The probiotic and gluten-free diet group (PRO-GFD) will receive one capsule containing the probiotic mixture powder (Sanprobi Stress; Sanprobi sp. z o.o., sp.k., Szczecin, Poland) in the amount of 3 × 10\^9 colony forming units (CFU) per day divided in two equal doses, comprising two bacteria strains: Lactobacillus helveticusRosell®-52, Bifidobacterium longumRosell®-175, and excipients: potato starch, magnesium stearate, and the capsule shell of hydroxypropyl methylcellulose. The participants will be asked to consume supplements before breakfast. The group will follow the elimination diet containing no gluten.
Study NCT04668131 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: acupuncture
Description: three times a week
Study NCT03332212 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: 12 weeks
Study NCT03877393 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplementation + gluten-free diet
Description: The placebo and gluten-free diet group (PLA-GFD) will receive one capsule containing only the excipients, i.e. maize starch, maltodextrins, and the capsule shell. The participants will be asked to consume supplements before breakfast. The group will follow the elimination diet containing no gluten.
Study NCT03877393 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation + gluten-containing diet
Description: The probiotic and gluten-containing diet group (PRO-GD) will receive one capsule containing the probiotic mixture powder (Sanprobi Stress; Sanprobi sp. z o.o., sp.k., Szczecin, Poland) in the amount of 3 × 10\^9 colony forming units (CFU) per day divided in two equal doses comprising two bacteria strains: Lactobacillus helveticusRosell®-52, Bifidobacterium longumRosell®-175 and excipients: potato starch, magnesium stearate, and the capsule shell of hydroxypropyl methylcellulose. The participants will be asked to consume supplements before breakfast. The group will stay with their current diet.
Study NCT03877393 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplementation + gluten-containing diet
Description: The placebo and gluten-containing diet group (PLA-GD) will receive one capsule containing only the excipients, i.e. maize starch, maltodextrins, and the capsule shell. The participants will be asked to consume supplements before breakfast. The group will stay with their current diet.
Study NCT03231384 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Description: In this study, the remote ischemic conditioning treatment was composed of five cycles of bilateral upper limb ischemia intervened by reperfusion, which was induced by two cuff placed around the upper arms respectively and inflated to 200 mm Hg for 5 minutes followed by 5 minutes of reperfusion by cuff deflation.~Doctormate, IPC-906
Study NCT03351049 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LAL
Description: Reactive support surface with a low air loss feature
Study NCT03351049 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-LAL
Description: Reactive support surface without a low air loss feature
Study NCT00841126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium iron hydroxycarbonate
Description: 500 mg tablets, administered orally: initial dosage 500 or 1000 mg (total daily dose 1500 or 3000 mg) depending on serum phosphate concentration, titrated to a maximum DAILY dose of 9000 mg). The total daily dose should be divided and taken with meals. Any SINGLE dose should not exceed 3000 mg.
Study NCT00841126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lanthanum carbonate
Description: 750 mg chewable tablets, administered orally: initial dosage 750 mg up to 3-times daily (total daily dose 2250 mg), titrated to a maximum SINGLE dose of 1500 mg (DAILY dose 3750 mg). The total daily dose should be divided and taken with meals.
Study NCT00841126 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0 mg (500 mg-size) tablets, administered orally: The total daily dose should be divided and taken with meals. Any SINGLE dose should not exceed 6 tablets.
Study NCT04382612 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HARPOON Beating Heart Mitral Valve Repair System (MVRS)
Description: Repair of the chordae tendinae in the mitral valve.
Study NCT02358824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-828
Description: Telmisartan 80mg /S-Amlodipine 5mg(FDC) Tablet, Oral, Once Daily~(1arm:2period and 4period, 2arm:1period and 3period)
Study NCT03332212 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 12 Weeks
Study NCT01658215 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: V0116 transdermal patch (Test treatment )
Study NCT01658215 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Nicotine transdermal patch (Reference treatment )
Study NCT02334839 — intervention group
Intervention type: OTHER
Intervention: Observational only
Description: Endothelial function will be assessed using ENDO-PAT (Itamar medical LTD, Caesarea, Israel) device, which evaluates the change in peripheral vascular tone in reaction to temporal ischemia in a process called Reactive Hyperemia (RH) .The RH-PAT is a blood pressure measurement-like cuff which is placed on the non-dominant arm. A pneumatic probe is placed on the index finger bilaterally (one serves as a control). After a baseline assessment for a 5 minutes period, the cuff is inflated to a 60mm Hg pressure above the systolic pressure in order to occlude the arterial flow distal to the brachial artery. After 5 minutes of occlusion, a prompt deflation of the cuff results in a RH response and vasodilatation in the distal arteries including those monitored in the index finger. The sensor translates the change in vascular tone and the ENDO-PAT V3.0.4 device analyzes the data automatically. The results are given in a RH index scale that reflects the level of reactive hyperemia.
Study NCT00975338 — intervention group
Intervention type: OTHER
Intervention: LIFEspan
Description: Rehabilitation services provided by an inter-disciplinary team of health professionals addressing the transfer of care to adult services and emerging needs related to transition to adulthood. LIFEspan staff are cross-appointed to both a pediatric and an adult hospital through a formally linked model of care.
Study NCT00975338 — intervention group
Intervention type: OTHER
Intervention: Non-LIFEspan
Description: Standard of care in the absence of a formal partnership between a pediatric and an adult hospital.
Study NCT04225416 — intervention group
Intervention type: OTHER
Intervention: Questionnaire/Structured Interview
Description: No intervention
Study NCT04513873 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Equipment to divert the focus of children
Description: The equipment was placed in an area where the children would be able to see easily during the blood collection process. It was turned on as soon as the children sat on to the chair where the process would take place to divert the focus of the children at the equipment.
Study NCT00759668 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acrysof Natural ReSTOR SN60D3
Description: Bilateral implantation with the AcrySof Natural ReSTOR Intraocular Lens (IOL) SN60D3 following cataract removal.
Study NCT00759668 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acrysof Natural Monofocal SN60AT
Description: Bilateral implantation with the AcrySof Natural Intraocular Lens (IOL) Model SN60AT following cataract removal.
Study NCT02473107 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Advanced caries lesions detection (no activity assessment)
Description: The diagnosis strategy will based on detection of only moderate and advanced caries lesions (ICDAS scores 3 to 6). Initial caries lesions will be considered as sound surfaces. Caries activity status will not be evaluated. Clinical decision-making will be proposed for all lesions detected, based on evidence-based protocols.
Study NCT02473107 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: All caries lesions detection (+activity assessment)
Description: The diagnosis strategy will based on detection of initial, moderate and advanced caries lesions (ICDAS scores 1 to 6). Caries activity status will be also evaluated. Clinical decision-making will be proposed for all active lesions detected, based on evidence-based protocols. inactive caries lesions will not be treated.
Study NCT03313388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Drink
Description: Beverage to be consumed
Study NCT03313388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Drink
Description: Beverage to be consumed
Study NCT01743664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMDR
Description: Patients in the experimental group will undergo 10 weekly sessions of 60 minutes each with EMDR following Shapiro's protocol for traumatic events
Study NCT01743664 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation
Description: The patients in the control group will undergo 10 weekly relaxation sessions that include diaphragmatic breathing, progressive muscle relaxation, visualization and rapid relaxation.
Study NCT00637598 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Mammography and tomosynthesis imaging
Description: All subjects receive the same radiation dose associated with mammography and tomosynthesis imaging (which is comparable to mammography).
Study NCT01261650 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation
Study NCT01261650 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham treatment
Study NCT02163278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DBPR108
Description: DBPR108 capsules in four doses beginning at 25 mg and rising to 600 mg.
Study NCT02163278 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: matching placebo
Description: Matching placebo capsules in four doses beginning at 25 mg and rising to 600 mg.
Study NCT03356366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI 3T
Description: Magnetic Resonance Imaging 3 Tesla
Study NCT03356366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI 1,5T
Description: Magnetic Resonance Imaging 1,5 Tesla
Study NCT03356366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI 7T
Description: Magnetic Resonance Imaging 7 Tesla
Study NCT00335985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB-0998
Description: 8 mL (400 mg of GB-0998)/kg per day is intravenously administered for five successive days
Study NCT00335985 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of GB-0998
Description: 8 mL/kg per day is intravenously administered for five successive days
Study NCT01445236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunosuppresion withdrawal
Description: Gradual discontinuation of all immunosuppressive drugs.
Study NCT02358824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Telmisartan
Description: - Telmisartan 80mg tablet, Oral, Once Daily (Combination Therapy with S-amlodipine)~(1arm:1period and 3period, 2arm: 2period and 4period)
Study NCT02358824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: S-amlodipine
Description: - S-amlodipine 5mg tablet, Oral, Once Daily (combination Therapy with Telmisartan)~(1arm:1period and 3period, 2arm: 2period and 4period)
Study NCT03969771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Description: The MBSR program was developed by the University of Massachusetts Medical School.